IDEXX Labs (IDXX) Lowers FY12 EPS Outlook
IDEXX Labs (Nasdaq: IDXX) reduced its FY12 EPS guidance from $3.07-$3.12 to $3.05-$3.10, which compares to the Street estimate of $3.10.
You May Also Be Interested In
- BofA/Merrill Lynch Upgrades Abaxis Inc. (ABAX) to Neutral
- Boston Properties, Inc. (BXP) Misses Q2 EPS by 1c
- UGI Corp. (UGI) Misses Q3 EPS by 2c
Create E-mail Alert Related CategoriesGuidance
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!